3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Neutropenia
5
Breast Neoplasms
5
Febrile Neutropenia
3
Wilms Tumor
1
Uterine Cervical Neoplasms
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Malignant Solid Tumors
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Hepatoblastoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Breastcancer
1
Breast Cancer Female
1
Interventions
Vincristine
10
Filgrastim
10
Cyclophosphamide
10
Doxorubicin
8
Etoposide
7
Radiotherapy
6
Dactinomycin
6
Carboplatin
6
Granulocyte Colony-Stimulating Factor
5
Topotecan
4
Polymerase Chain Reaction
4
Gene Expression Profiling
4
sargramostim
3
Temozolomide
3
Reverse Transcriptase Polymerase Chain Reaction
3
Peripheral Blood Stem Cell Transplantation
3
Melphalan
3
Itraconazole
3
Irinotecan
3
Ifosfamide
3
DNA Methylation
3
Cisplatin
3
Busulfan
3
liposomal amphotericin B
2
ixabepilone
2
X-Rays
2
Voriconazole
2
Therapeutics
2
Stem Cell Transplantation
2
Specimen Handling
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Wilms Tumor
×
pegylated granulocyte colony-stimulating factor
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled